Skip to Content

GenVec, Inc. (NASDAQ: GNVC)

Merger

Overview
  • Date:
  • 4/4/2017
  • Company Name - Buyer:
  • Intrexon Corporation
  • Status:
  • Closed/Complete
  • Merger Announcement Date:
  • 1/24/2017
  • Court:
  • U.S. Bankruptcy Court: District of Delaware

Case Finder

Locate any case using the tools below.

NEW YORK, April 4, 2017 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons or entities who held GenVec, Inc. (NASDAQ: GNVC) securities on March 28, 2017 (the “Class Period”).

On January 24, 2017, the two parties announced the signing of a definitive merger agreement pursuant to which Intrexon Corporation will acquire GenVec in a deal worth $15.9 million. As a result of the merger, Neustar shareholders are only anticipated to receive 0.297 Intrexon shares and one contingent consideration equal to 50% of any milestone or royalty payments received within 36 months after the closing of the transaction for each share of GenVec common stock.

The Complaint alleges that the Company failed to conduct a fair sales process and failed to disclose all material information regarding the sale of the Company.

If you held GenVec securities during the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa A. Fortunato, Esq. by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: